Literature DB >> 29952591

An evaluation of the predictive validity of the SAVRY and YLS/CMI in justice-involved youth with fetal alcohol spectrum disorder.

Kaitlyn McLachlan1, Andrew L Gray2, Ronald Roesch2, Kevin S Douglas2, Jodi L Viljoen2.   

Abstract

Despite the high prevalence of fetal alcohol spectrum disorder (FASD) in youth criminal justice settings, there is currently no research supporting the use of violence risk assessment tools in this population. This study examined the predictive validity of the Structured Assessment of Violence Risk in Youth (SAVRY) and the Youth Level of Service/Case Management Inventory (YLS/CMI) in justice-involved youth with FASD. Participants were 100 justice-involved youth (ages 12-23; 81% male), including 50 diagnosed with FASD and 50 without FASD or prenatal alcohol exposure. The SAVRY and YLS/CMI were prospectively coded based on interview and file review, with recidivism (both any and violent specifically) coded 1-year post-baseline assessment. Results provide preliminary support for the validity of the SAVRY and YLS/CMI in predicting recidivism in justice-involved youth with FASD. Higher ratings across SAVRY and YLS/CMI domains were found in youth with FASD, underscoring a critical need for assessments and interventions to buffer recidivism risk and address clinical needs. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Year:  2018        PMID: 29952591     DOI: 10.1037/pas0000612

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  2 in total

1.  Risk, rights and deservedness: Navigating the tensions of Gladue, Fetal Alcohol Spectrum Disorder and settler colonialism in Canadian courts.

Authors:  Jane Dickson; Michelle Stewart
Journal:  Behav Sci Law       Date:  2021-10-27

Review 2.  Understanding the Relationship between Fetal Alcohol Spectrum Disorder (FASD) and Criminal Justice: A Systematic Review.

Authors:  Francesco Sessa; Monica Salerno; Massimiliano Esposito; Nunzio Di Nunno; Giuseppe Li Rosi; Salvatore Roccuzzo; Cristoforo Pomara
Journal:  Healthcare (Basel)       Date:  2022-01-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.